Analysis Article • 10h

Over the last 7 days, the Life Sciences industry has dropped 3.4%, driven by a pullback from AddLife of 7.0%. On the other hand MedCap is actually up 5.7%. The industry has fallen 19% in the last year. Looking forward, earnings are forecast to grow by 18% annually.
Has the Swedish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 24 Jul 2026 | SEK 29.7b | SEK 14.8b | -SEK 825,373,579.00 | 34.2x | -36x | 2x |
| Sun, 21 Jun 2026 | SEK 28.9b | SEK 14.6b | -SEK 871,304,353.00 | 33.4x | -33.1x | 2x |
| Tue, 19 May 2026 | SEK 28.4b | SEK 14.6b | -SEK 850,163,077.00 | 35.4x | -33.4x | 1.9x |
| Thu, 16 Apr 2026 | SEK 30.3b | SEK 14.6b | -SEK 971,664,077.00 | 34.8x | -31.1x | 2.1x |
| Sat, 14 Mar 2026 | SEK 26.9b | SEK 14.6b | -SEK 838,374,077.00 | 32.4x | -32.1x | 1.8x |
| Mon, 09 Feb 2026 | SEK 29.9b | SEK 14.8b | -SEK 578,515,427.00 | 41.7x | -51.8x | 2x |
| Wed, 07 Jan 2026 | SEK 29.9b | SEK 14.9b | -SEK 744,515,427.00 | 46.6x | -40.2x | 2x |
| Fri, 05 Dec 2025 | SEK 33.9b | SEK 14.9b | -SEK 744,515,427.00 | 56.6x | -45.6x | 2.3x |
| Sun, 02 Nov 2025 | SEK 38.0b | SEK 14.8b | SEK 117.3m | 56.5x | 323.8x | 2.6x |
| Tue, 30 Sep 2025 | SEK 34.1b | SEK 14.7b | SEK 61.3m | 56.9x | 557.3x | 2.3x |
| Thu, 28 Aug 2025 | SEK 35.2b | SEK 14.7b | SEK 59.9m | 62.4x | 588.8x | 2.4x |
| Sat, 26 Jul 2025 | SEK 36.7b | SEK 14.8b | SEK 186.0m | 65.8x | 197.2x | 2.5x |
| Mon, 23 Jun 2025 | SEK 45.9b | SEK 16.6b | SEK 405.8m | 73.2x | 113.1x | 2.8x |
| Wed, 21 May 2025 | SEK 45.9b | SEK 16.6b | SEK 415.0m | 44.5x | 110.5x | 2.8x |
| Fri, 18 Apr 2025 | SEK 36.9b | SEK 16.6b | SEK 609.4m | 39.6x | 60.5x | 2.2x |
| Sun, 16 Mar 2025 | SEK 38.0b | SEK 16.6b | SEK 614.9m | 38.5x | 61.8x | 2.3x |
| Tue, 11 Feb 2025 | SEK 43.4b | SEK 17.0b | -SEK 1,038,511,426.00 | 42.9x | -41.8x | 2.6x |
| Thu, 09 Jan 2025 | SEK 43.3b | SEK 16.7b | -SEK 1,152,911,426.00 | 50.5x | -37.5x | 2.6x |
| Sat, 07 Dec 2024 | SEK 43.4b | SEK 16.7b | -SEK 1,154,323,426.00 | 50.1x | -37.6x | 2.6x |
| Mon, 04 Nov 2024 | SEK 43.2b | SEK 16.8b | -SEK 958,019,827.00 | 49.4x | -45.1x | 2.6x |
| Wed, 02 Oct 2024 | SEK 47.6b | SEK 16.7b | -SEK 988,175,491.00 | 58.8x | -48.1x | 2.9x |
| Fri, 30 Aug 2024 | SEK 49.2b | SEK 16.7b | -SEK 987,374,492.00 | 62.1x | -49.8x | 2.9x |
| Sun, 28 Jul 2024 | SEK 49.5b | SEK 16.7b | -SEK 1,128,120,510.00 | 62.6x | -43.8x | 3x |
| Tue, 25 Jun 2024 | SEK 42.3b | SEK 16.3b | -SEK 1,188,686,510.00 | 55.3x | -35.6x | 2.6x |
| Thu, 23 May 2024 | SEK 42.3b | SEK 16.3b | -SEK 1,188,529,510.00 | 60.8x | -35.6x | 2.6x |
| Sat, 20 Apr 2024 | SEK 37.1b | SEK 16.0b | -SEK 1,122,792,213.00 | 34.6x | -33x | 2.3x |
| Mon, 18 Mar 2024 | SEK 38.7b | SEK 16.0b | -SEK 1,123,139,210.00 | 33.4x | -34.5x | 2.4x |
| Wed, 14 Feb 2024 | SEK 38.3b | SEK 15.8b | -SEK 1,473,823,683.00 | 57.3x | -26x | 2.4x |
| Fri, 12 Jan 2024 | SEK 36.9b | SEK 15.5b | -SEK 1,393,723,683.00 | 45.2x | -26.5x | 2.4x |
| Sun, 10 Dec 2023 | SEK 36.5b | SEK 15.5b | -SEK 1,393,723,683.00 | 44.2x | -26.2x | 2.4x |
| Tue, 07 Nov 2023 | SEK 31.1b | SEK 15.4b | -SEK 1,256,647,710.00 | 34x | -24.8x | 2x |
| Thu, 05 Oct 2023 | SEK 26.5b | SEK 15.1b | -SEK 1,134,516,711.00 | 36.2x | -23.4x | 1.8x |
| Sat, 02 Sep 2023 | SEK 30.6b | SEK 15.1b | -SEK 1,134,263,831.00 | 42.1x | -27x | 2x |
| Mon, 31 Jul 2023 | SEK 33.2b | SEK 15.1b | -SEK 213,871,038.00 | 47.3x | -155x | 2.2x |
-155x
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | -0.31% | |
| Healthcare | -2.23% | |
| Life Sciences | -3.41% | |
| Clinical Research and Equipment | -3.41% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MCAP MedCap | SEK 549.00 | 5.7% +SEK 419.2m | -12.9% | PE34.2x | |
| GENO Genovis AB (publ.) | SEK 19.02 | 0.5% +SEK 6.6m | -34.0% | PE51.7x | |
| IDLDX IDL Diagnostics | SEK 0.40 | 0.5% +SEK 460.7k | -23.0% | PS1.7x |